|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-10-29 Sale |
2008-10-30 3:30 pm | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 4,000 | $38.23 | $152,920 | 117,000 (Direct) | View |
| 2007-08-21 Sale |
2007-08-24 2:29 pm | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 500 | $58.98 | $29,491 | 58,500 (Direct) |
View |
| 2007-01-10 Sale |
2007-01-11 4:22 pm |
ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 2,000 | $39.37 | $78,730 | 55,000 (Direct) |
View |
| 2005-06-08 Sale |
2005-06-08 4:17 pm | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 1,800 | $21.88 | $39,384 | 55,000 (Direct) |
View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount | Shares Ownership |
Filing |
| 2008-10-29 Exercise |
2008-10-30 3:30 pm | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 4,000 | $5.88 | $23,520 | 121,000 (Direct) | View |
| 2008-01-09 Option Award | 2008-01-17 09:18 am |
ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 2,000 | $0 | $0 | 60,500 (Direct) | View |
| 2007-08-21 Exercise | 2007-08-24 2:29 pm | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 2,000 | $10.38 | $20,760 | 59,000 (Direct) | View |
| 2007-01-15 Option Award | 2007-01-18 3:34 pm | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 2,000 | $0 | $0 | 57,000 (Direct) |
View |
| 2006-01-09 Option Award | 2006-01-11 11:15 am | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 2,000 | $20.72 | $41,440 | 57,000 (Direct) |
View |
| 2005-06-08 Exercise | 2005-06-08 4:17 pm | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 6,800 | $2.375 | $16,150 | 56,800 (Direct) |
View |
| Transaction & Date |
Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2008-05-09 Option Award |
2008-05-30 11:46 am |
N/A 2018-05-09 | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 7,500 | $72.03 | 7,500 (Direct) |
View |
| 2007-08-21 Exercise | 2007-08-24 2:29 pm | 1997-12-11 2007-12-11 | ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 2,000 | $10.38 | 0 (Direct) |
View |
| 2007-05-03 Option Award |
2007-05-07 1:18 pm | N/A 2017-05-03 |
ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 7,500 | $43.36 | 7,500 (Direct) | View |
| 2006-06-07 Option Award |
2006-06-09 4:10 pm | N/A 2016-06-07 |
ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 7,500 | $32.7 | 7,500 (Direct) | View |
| 2005-12-09 Option Award | 2005-12-13 1:59 pm |
N/A 2015-12-09 |
ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 7,500 | $19.73 | 7,500 (Direct) | View |
| 2005-06-08 Exercise |
2005-06-08 4:17 pm | 1998-07-06 2005-07-06 |
ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 6,800 | $2.375 | 0 (Direct) |
View |
| 2004-12-10 Option Award |
2004-12-14 4:19 pm |
N/A 2014-12-10 |
ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 7,500 | $22.21 | 7,500 (Direct) | View |
| 2003-12-16 Option Award | 2003-12-17 11:01 am | N/A 2013-12-16 |
ALEXION PHARMACEUTICALS INC | ALXN | MADRI JOSEPH A (Director) | 7,500 | $17.05 | 7,500 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Mon, 01 Dec 2008 13:44:10 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |